Загрузка...
Antitumor activity of a folate receptor-targeted immunoglobulin G-doxorubicin conjugate
Development of antibody-drug conjugates (ADCs) is a promising therapeutic strategy for cancer therapy. In this study, folate was conjugated via a polyethyleneglycol (PEG) linker to immunoglobulin G (IgG), which was linked to doxorubicin (DOX), to form a novel ADC folate-PEG-IgG-DOX (FA-PEG-IgG-DOX)....
Сохранить в:
| Опубликовано в: : | Int J Nanomedicine |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5383082/ https://ncbi.nlm.nih.gov/pubmed/28408821 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S125591 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|